You will receive alerts when there are new announcements on Pharmaxis Ltd
Only registered members can use this feature.
Pharmaxis Ltd (ASX:PXS) is an Australian pharmaceutical research company with expertise in developing drugs for inflammatory and fibrotic diseases and focussed on myelofibrosis.
The company expects to announce receipt of milestone payments and the start of sales from its Bronchitol treatment in the near-term.
Copyright © Proactive Investors 2020.
All Rights Reserved - Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.